Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults

被引：0

作者：

Tu, Sanfang ^{[1
]}

Zhou, Lijuan ^{[1
]}

Huang, Rui ^{[1
]}

Zhou, Xuan ^{[1
]}

Yang, Jilong ^{[1
]}

Li, Meifang ^{[1
]}

Jin, Bo ^{[1
]}

Wang, Langqi ^{[1
]}

Zhuo, Yaqi ^{[1
]}

Chen, Huifang ^{[1
]}

Chang, Lung-Ji ^{[2
,3
]}

Li, Yuhua ^{[1
]}

机构：

[1] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China

[2] Univ Elect Sci & Technol China, Sch Med, Chengdu, Peoples R China

[3] Geno Immue Med Inst, Shenzhen, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186622

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia
Shi, Ming
Li, Li
Wang, Shiyuan
Cheng, Hai
Chen, Wei
Sang, Wei
Qi, Kunming
Li, Zhenyu
Wang, Gang
Li, Huizhong
Lan, Jianping
Huang, Jinqi
Fei, Xiaoming
Yu, Min
Li, Fei
Qiao, Jianlin
Wu, Qingyun
Zeng, Lingyu
Jing, Guangjun
Zheng, Junnian
Gale, Robert Peter
Xu, Kailin
Cao, Jiang
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 711 - 718
[2] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
Wang, Yiyun
Yang, Yingying
Hong, Ruimin
Zhao, Houli
Wei, Guoqing
Wu, Wenjun
Xu, Huijun
Cui, Jiazhen
Zhang, Yanlei
Chang, Alex H.
Hu, Yongxian
Huang, He
BLOOD CANCER JOURNAL, 2020, 10 (10)
[3] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
Yiyun Wang
Yingying Yang
Ruimin Hong
Houli Zhao
Guoqing Wei
Wenjun Wu
Huijun Xu
Jiazhen Cui
Yanlei Zhang
Alex H. Chang
Yongxian Hu
He Huang
Blood Cancer Journal, 10
[4] Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Dai, Hanren
Wu, Zhiqiang
Jia, Hejin
Tong, Chuan
Guo, Yelei
Ti, Dongdong
Han, Xiao
Liu, Yang
Zhang, Wenying
Wang, Chunmeng
Zhang, Yajing
Chen, Meixia
Yang, Qingming
Wang, Yao
Han, Weidong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[5] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Gu, Runxia
Liu, Fang
Zou, Dehui
Xu, Yingxi
Lu, Yang
Liu, Bingcheng
Liu, Wei
Chen, Xiaojuan
Liu, Kaiqi
Guo, Ye
Gong, Xiaoyuan
Lv, Rui
Chen, Xia
Zhou, Chunlin
Zhong, Mengjun
Wang, Huijun
Wei, Hui
Mi, Yingchang
Qiu, Lugui
Lv, Lulu
Wang, Min
Wang, Ying
Zhu, Xiaofan
Wang, Jianxiang
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[6] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Runxia Gu
Fang Liu
Dehui Zou
Yingxi Xu
Yang Lu
Bingcheng Liu
Wei Liu
Xiaojuan Chen
Kaiqi Liu
Ye Guo
Xiaoyuan Gong
Rui Lv
Xia Chen
Chunlin Zhou
Mengjun Zhong
Huijun Wang
Hui Wei
Yingchang Mi
Lugui Qiu
Lulu Lv
Min Wang
Ying Wang
Xiaofan Zhu
Jianxiang Wang
Journal of Hematology & Oncology, 13
[7] Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Hanren Dai
Zhiqiang Wu
Hejin Jia
Chuan Tong
Yelei Guo
Dongdong Ti
Xiao Han
Yang Liu
Wenying Zhang
Chunmeng Wang
Yajing Zhang
Meixia Chen
Qingming Yang
Yao Wang
Weidong Han
Journal of Hematology & Oncology, 13
[8] Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma
Xu, Hao
Lv, Qiuxia
Huang, Liang
Cao, Wenyue
Wang, Jue
Meng, Fankai
Li, Chunrui
Zheng, Miao
Chen, Liting
Mu, Ketao
Cheng, Jiali
Zhu, Li
Zhou, Jianfeng
Zhang, Yicheng
Wang, Na
Cao, Yang
CYTOTHERAPY, 2023, 25 (02) : 185 - 191
[9] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy with Dual Targeting of CD19 and CD70 to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Tu, Sanfang
Zhou, Lijuan
Huang, Rui
Zhou, Xuan
Yang, Jilong
Li, Meifang
Jin, Bo
Wang, Langqi
Zhuo, Yaqi
Chen, Huifang
Chang, Lung-Ji
Li, Yuhua
BLOOD, 2023, 142
[10] Sequential treatment with anti-CD19 and CD22 chimeric antigen receptor T cells in children with relapsed or refractory B acute lymphoblastic leukemia
Chanut, Mathilde
HEMATOLOGIE, 2023, 29 (06): : 332 - 334

← 1 2 3 4 5 →